Erythropoietin/Cancer

特許 係属中 Erythropoietins available for use as therapeutic agents are produced by recombinant DNA technology in cell culture, and include Epogen/Procrit (epoetin alfa) and Aranesp (darbepoetin alfa); they are used in treating anemia resulting from chronic kidney disease, inflammatory bowel disease (Crohn's disease and ulcer colitis) [18] and myelodysplasia from the treatment of cancer (chemotherapy and radiation).